Full feature

More coverage:

  • TheStreet: Gilead Sciences Bucks Tradition, Takes ‘Low Road’ on New Hepatitis C Drug Price More
  • FierceBiotech: New Gilead hep C combo Epclusa gains FDA approval More
  • STAT: FDA approves a Gilead pill that is first to treat all forms of hepatitis C More